Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DONEPEZIL HYDROCHLORIDE
- A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.
- Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male Volunteers
- Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
- A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
- Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
- Technical R&D and Demonstration of Intelligent Medical Care in Alzheimer's Disease's Management
- δ in Dementia Clinical Trials
- Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy
- Efficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's Disease
- Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers
- Effect of Donepezil on Speech Recognition in Cochlear Implant Users
- Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
- A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
- Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study
- Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture
- ALDH Enzyme in CRF With Advanced GI Cancer
- Effects of Acetylcholine and Attention on Visual Spatial Representations in the Brain
- Effect of Hydralazine on Alzheimer's Disease
- Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease
- Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
- Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
- Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
- The Effect of Donepezil on Glycemic Control in Type II Diabetics
- The Effect of Donepezil on Wound Healing
- A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
- Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
- Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction
- MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
- Monitoring Anti-Dementia Drugs by Serum Levels
- Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
- The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.
- A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other
- Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
- Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
- A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
- The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
- Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
- A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
- A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
- A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations
- Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
- A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
- A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
- Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea
- A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
- A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
- A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
- Noradrenergic Add-on Therapy With Guanfacine
- Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
- Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
- Detecting an Early Response to Donepezil With Measures of Visual Attention
- Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
- Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
- Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease
- Memory and Mental Health in Aging
- Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
- A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
- Donepezil Attenuate Postoperative Cognitive Dysfunction
- TAK-071 Scopolamine-Induced Cognitive Impairment Study
- Comparison of Taste and Palatability in Fiber Supplements
- CPC-201 Alzheimer's Disease Type Dementia: PET Study
- A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
- Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
- Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
- Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
- Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
- The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
- DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil
- NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.
- Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
- A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
- A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
- Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects
- Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
- Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
- SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
- Gastrointestinal Motility Among Diabetes Patients
- Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
- A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
- A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)
- Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders
- Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia
- Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)
- Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
- Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07
- The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia
- A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants
- Pharmacovigilance in Gerontopsychiatric Patients
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
- BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
- Donepezil Memory Preservation Post ECT
- Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease
- The Impact of Arousal Threshold in Obstructive Sleep Apnea
- Multicenter Evaluation of Memory Remediation After TBI With Donepezil
- Cholinesterase Inhibitor Discontinuation
- Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage
- Effects of Cholinergic Augmentation on Measures of Balance and Gait
- The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
- A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
- Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
- Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
- A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
- Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
- Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
- Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
- Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
- A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
- Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
- Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
- Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
- Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition
- Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition
- The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
- A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
- Masitinib in Patients With Mild to Moderate Alzheimer's Disease
- A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
- Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
- Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
- A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males
- Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
- Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
- Donepezil Effect on Visual Attention and Training
- Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil
- A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
- Combination Treatment Study for Memory Impairment and Depression
- Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial
- Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
- Treatment of Residual Amblyopia With Donepezil
- Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
- Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
- Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
- The Effect of Donepezil on Gait and Balance in Parkinson's Disease
- Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition
- Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition
- Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
- A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
- Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development
- Gabapentin and Donepezil Combination on Experimental Human Pain Models
- Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
- Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
- Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
- Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
- Efficacy and Safety Study of Shenwu Capsule
- Donepezil Trial for Motor Recovery in Acute Stroke
- Donepezil 10 mg Tablets Under Fed Conditions
- Donepezil 10 mg Tablets Under Fasting Conditions
- Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting Conditions
- Cilostazol Augmentation Study in Dementia
- A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
- Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI
- Comparative Research of Alzheimer's Disease Drugs
- Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults
- Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
- Pharmacokinetic Comparisons of Two Donepezil Formulations
- A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
- Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
- Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions
- Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
- Study of STA-1 as an Add-on Treatment to Donepezil
- Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
- Effect of Donepezil on Smoking
- An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
- Scopolamine Challenge Study
- Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
- The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
- Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
- An Extension of the CONCERT Protocol (DIM18)
- An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis
- Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
- Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
- To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease
- Randomized Controlled Study of Donepezil in Fragile X Syndrome
- A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects
- Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
- Rivastigmine as a Treatment for Methamphetamine Dependence
- Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
- Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
- A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
- Drug-Drug Interaction Study With Aricept® (Donepezil)
- 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
- A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
- The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
- Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
- Clinical Trial of Donepezil Between the Naive Group and the Switching Group
- Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease
- Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
- Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
- Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
- A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
- Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
- Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain
- Study Evaluating The Coadministration of Begacestat And Donepezil
- Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
- Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
- Donepezil and the Risk of Falls in Seniors With Cognitive Impairment
- A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
- Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
- Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease
- Donepezil Treatment for Sleep Apnea Patients
- Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
- Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
- BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
- A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
- A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
- Enhancing Rehabilitation After Stroke
- Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
- Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
- Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
- Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
- Mayo Acute Stroke Trial for Enhancing Recovery
- fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults
- Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
- Corticolimbic Degeneration and Treatment of Dementia
- Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
- Alzheimer and Sleep
- Efficacy of Rivastigmine in Patients With Down Syndrome
- Pharmacokinetic Interaction Between AZD3480 and Donepezil
- Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
- A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
- Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
- Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
- Progression Delaying Effect of Escitalopram in Alzheimer's Disease
- The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism
- Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
- Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
- Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
- A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease
- Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
- Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease
- Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period
- The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
- Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease
- A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
- Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
- Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment
- Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects
- Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
- Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
- A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI
- Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
- The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
- Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
- Neural Correlates In Mild Alzheimer's Disease
- Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease
- Use of Donepezil for Treatment of Cocaine Dependence
- Donepezil Double Blind Trial for ECT Memory Disfunction
- Aricept to Improve Functional Tasks in Vascular Dementia
- Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
- Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
- Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
- Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
- Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
- Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
- Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
- The Effect of Donepezil on Sedation and Other Symptoms
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
- SB-742457 And Donepezil In Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
- A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties
- The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
- Brain Imaging and Mental Disorders of Aging Intervention
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
- EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
- Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
- Prevention of Postoperative Delirium With Donepezil
- An Open-Label Trial of Donepezil in Fragile X Syndrome
- The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
- The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia
- Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial
- Donepezil Treatment of Psychotic Symptoms in Dementia Patients
- Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
- Donepezil in Preventing Delirium in Hospitalized Elderly
- Donepezil in the Prevention of Post-Operative Cognitive Decline
- Memantine in Systemic Lupus Erythematosus
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression
- Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
- Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
- The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia
- Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
- Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
- Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
- Alzheimer's Disease Long-term Follow-up Study (ALF Study)
- Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease
- Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)
- Modafinil in Multiple Sclerosis
- CALM-AD
- Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy
- The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
- Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
- Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
- Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
- Improving Memory in Patients With Multiple Sclerosis
- Donepezil HCl & Cognitive Deficits in Autism
- Memory and Mental Health in Aging
- Treatment for Early Memory Loss
- A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
- Donepezil to Treat Dementia in Parkinson's Disease
- Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9
- Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
- Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
- Study of the Pathogenesis of Rett Syndrome
- Memory Impairment Study (Mild Cognitive Impairment Study)
Clinical trials list
click for details